SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Nakanishi M, Kuriyama A, Onodera M. Acute Med. Surg. 2020; 7(1): e475.

Affiliation

Emergency and Critical Care Center Kurashiki Central Hospital Okayama Japan.

Copyright

(Copyright © 2020, Japanese Association for Acute Medicine, Publisher John Wiley and Sons)

DOI

10.1002/ams2.475

PMID

31988787

PMCID

PMC6971462

Abstract

BACKGROUND: Cardiovascular dysfunction is the main manifestation of β-blocker intoxication; however, respiratory manifestations have rarely been reported. CASE PRESENTATION: A 41-year-old man, who had ingested 300 mg carvedilol in a suicide attempt, was transferred to our emergency department. The patient had wheezing on arrival; however, he had no known history of bronchial asthma. In the absence of signs of heart failure, we gave the patient inhaled procaterol, a short-acting β2 agonist. The wheezing disappeared approximately 60 h after carvedilol ingestion and did not recur thereafter.

CONCLUSION: We report a case of wheezing caused by carvedilol intoxication. Although rare, clinicians should recognize that wheezing or bronchospasm can develop following β-blocker intoxication, for which a short-acting β2 agonist could be indicated.

© 2019 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.


Language: en

Keywords

bronchospasm; carvedilol; procaterol; wheezing; β‐blocker

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print